Insulin Degludec — A New Ultralong-Acting Insulin
- Brett, Allan S. MD
NEJM Journal Watch :p JW201301030000002, 2013. | DOI: 10.1056/JW201301030000002
The FDA currently is evaluating this drug, but concern about cardiovascular risk lurks in the background.
Copyright © 2013 Massachusetts Medical Society. All rights reserved.